MELINA-THEONI GYPARAKI ATHANASIOS G. PAPAVASSILIOU
Epigenetic changes play a key role in the regulation of several
genes in ovarian cancer. Understanding the mechanisms underpinning
these changes is essential, because such understanding could
contribute to the development of novel therapeutic targets with
improved efficacy. Additionally, it could also contribute to the
development of biomarkers and biomarker panels that could serve as
prognostic, predictive, and/or diagnostic tools in ovarian cancer.